Relmada Therapeutics Inc (RLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,052 | -57,385 | -37,517 | -27,426 | -17,560 |
| Accounts payable and accrued liabilities | 1,763 | -2,562 | -2,678 | -2,769 | -2,866 |
| Other Working Capital | 2,478 | -2,893 | -4,966 | -4,717 | -4,767 |
| Other Operating Activity | -256 | 17,053 | 13,971 | 10,443 | 7,125 |
| Operating Cash Flow | $-15,068 | $-45,787 | $-31,191 | $-24,469 | $-18,067 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -135,227 | -48,138 | 28,791 | 22,038 | 15,360 |
| Investing Cash Flow | $-135,227 | $-48,138 | $28,791 | $22,038 | $15,360 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 160,000 | 93,638 | 0 | 0 | N/A |
| Other Financing Activity | -3,426 | -73 | -73 | -73 | 0 |
| Financing Cash Flow | $156,574 | $93,565 | $-73 | $-73 | $0 |
| Beginning Cash Position | 3,497 | 3,857 | 3,857 | 3,857 | 3,857 |
| End Cash Position | 9,776 | 3,497 | 1,385 | 1,353 | 1,150 |
| Net Cash Flow | $6,280 | $-361 | $-2,473 | $-2,504 | $-2,707 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,068 | -45,787 | -31,191 | -24,469 | -18,067 |
| Free Cash Flow | -15,068 | -45,787 | -31,191 | -24,469 | -18,067 |